Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 18/20 | 0.61 |
| ▸ | PIK3CD | O00329 | 9/20 | 0.61 |
| ▸ | PIK3CG | P48736 | 9/20 | 0.61 |
| ▸ | PIK3CB | P42338 | 8/20 | 0.61 |
| ▸ | PIK3R1 | P27986 | 5/20 | 0.56 |
| ▸ | MTOR | P42345 | 2/20 | 0.56 |
| ▸ | PI4KA | P42356 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL462084 | 0.86 | PIK3CA (0.61) | PIK3CAPIK3CDPIK3CGPIK3CBPIK3R1 | |
| SCHEMBL453081 | 0.83 | PIK3CA (0.61) | PIK3CAPIK3CDPIK3CGPIK3CBPIK3R1 | |
| SCHEMBL454938 | 0.83 | PIK3CA (0.57) | PIK3CAPIK3CDPIK3CGPIK3CBPIK3R1 | |
| SCHEMBL451324 | 0.82 | PIK3CA (0.57) | PIK3CAPIK3CDPIK3CGPIK3CBPIK3R1 | |
| SCHEMBL18995684 | 0.81 | PIK3CA (0.73) | PIK3CAPIK3CDPIK3CGPIK3CBPIK3R1 | |
| SCHEMBL455765 | 0.81 | PIK3CA (0.55) | PIK3CAPIK3CDPIK3CGPIK3CBPIK3R1 | |
| SCHEMBL454735 | 0.81 | PIK3CG (0.56) | PIK3CAPIK3CDPIK3CGPIK3CBPIK3R1 | |
| SCHEMBL15975806 | 0.80 | PIK3CA (0.56) | PIK3CAPIK3CDPIK3CGPIK3CBPIK3R1 | |
| SCHEMBL532206 | 0.80 | PIK3CA (0.54) | PIK3CAPIK3CDPIK3CGPIK3CBPIK3R1 | |
| SCHEMBL452518 | 0.80 | PIK3CA (0.59) | PIK3CAPIK3CDPIK3CGPIK3CBMTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011121317-A9 | IMIDAZOTHIADIAZOLES FOR USE AS KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS (CNIO) (ES) | 2012-03-15 | — | — | WO | disclosed |